PREMORBID SMOKING, ALCOHOL-CONSUMPTION, AND COFFEE-DRINKING HABITS IN PARKINSONS-DISEASE - A CASE-CONTROL STUDY

被引:87
作者
JIMENEZJIMENEZ, FJ [1 ]
MATEO, D [1 ]
GIMENEZROLDAN, S [1 ]
机构
[1] HOSP GEN GREGORIO MARANON,DEPT NEUROL,MADRID,SPAIN
关键词
PREMORBID HABITS; SMOKING; ALCOHOL DRINKING; COFFEE DRINKING; PARKINSONS DISEASE; CASE CONTROL STUDY;
D O I
10.1002/mds.870070407
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A number of studies have reported lower cigarette consumption in patients with Parkinson's disease (PD) previous to onset of the disease. In an attempt to determine whether there existed a "premorbid attitude" by patients against the use of socially accepted "drugs," the premorbid tobacco, alcohol, and coffee consumption habits were compared in 128 PD patients and 256 controls. Patients and controls were selected by case control method and were recruited from the same health area and socioeconomic stratum. In males, the habits of smoking more than 10 cigarettes/day (p < 0.001) and drinking more than 50 g/day of alcohol (p < 0.001) were significantly less frequent in the PD patients than in the controls, but the differences in coffee consumption were nonsignificant. In females behavior did not differ significantly between the PD group and the controls for any of the three habits. There was no correlation between the amount of smoking and alcohol drinking and age at onset of PD or current Hoehn and Yahr's staging. Our results suggest the existence of a premorbid personality in males with PD, possibly conditioning a restrictive attitude toward the consumption of such toxic substances as tobacco and alcohol, yet a more tolerant attitude toward habits more widely accepted socially, like coffee consumption.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 40 条
[31]  
Irwin I, Langston JW, DeLanney LE., 4‐phenylpyridine (4 PP) and MPTP: the relationshipbetween striatal MPP<sup>+</sup> concentrations and neurotoxicity, Life Sci, 40, pp. 731-740, (1987)
[32]  
Carr LA, Rowell PP., Attenuation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity by tobacco smoke, Neuropharmacology, 29, pp. 311-314, (1990)
[33]  
Golbe LI, Cody RA, Duvoisin RC., Smoking and Parkinson's disease. Search for a dose‐response relationship, Arch Neurol, 43, pp. 774-778, (1986)
[34]  
Poewe W, Gerstenbrand F, Ransmayr G, Plorer S., Premorbid personality of Parkinson patients, J Neural Transm, 19, pp. 215-224, (1983)
[35]  
Lees AJ., The behavioural neurology of Parkinson's disease, Parkinson's disease, pp. 389-413, (1990)
[36]  
Ogawa H, Tominaga S, Kubo N, Et al., Shinshin Igaku [Psychosom Med], 24, pp. 467-477, (1984)
[37]  
Jimenez-Jimenez FJ, Santos J, Molina-Arjona JA, Zancada F, Roldan A, Fernandez-Ballesteros A., (1989)
[38]  
Ricklan M, Weiner H, Diller L., Somato‐Psychologic studies in Parkinson's disease. An investigation into the relationship of certain disease factors to psychological functions, The Journal of Nervous and Mental Disease, 129, pp. 263-272, (1959)
[39]  
De Ajuriaguerra J., Étude psychopathologique des parkinsoniens, Monoamines Noyaux gris Centraux et syndrome de Parkinson, pp. 327-351, (1971)
[40]  
Carlen PL, Lee MA, Jacob M, Livshits O., Parkinsonism provoked by alcoholism, Ann Neurol, 9, pp. 84-86, (1981)